RBC Capital Starts Optinose (OPTN) at Outperform

November 7, 2017 4:36 AM UTC Send to a Friend
RBC Capital initiates coverage on Optinose (NASDAQ: OPTN) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login